Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1621 of 5804
-
Could a cheap pill fix stiff arteries in insulin resistance?
Disease control CompletedTo determine whether treatment with the ENaC inhibitor, amiloride, improves endothelial function and arterial stiffness in obese insulin resistant subjects in a randomized placebo-controlled trial examining pre and postmenopausal women and age-matched men.
Phase: PHASE2, PHASE3 • Sponsor: University of Missouri-Columbia • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug shows promise in controlling transplant complications
Disease control CompletedThis is a multi-center study to evaluate the safety, tolerability, PK, PD, and clinical activity of EQ001 in subjects with Acute Graft Versus Host Disease (aGVHD).
Phase: PHASE1, PHASE2 • Sponsor: Biocon Limited • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug cocktail targets Hard-to-Treat brain tumors
Disease control Recruiting nowthis research study is evaluating the highest dose of ASTX727 that can be administered safely to recurrent/progressive non-enhancing IDH mutant gliomas patients.
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Nerve surgery offers hope for breast cancer survivors in chronic pain
Symptom relief CompletedPost-mastectomy pain due to nerve injury leads to long-term opioid use and diminished quality-of-life. The investigators on this study will evaluate the regenerative peripheral nerve interface (RPNI), a novel surgical approach to neuroma treatment, to improve patient-reported pos…
Phase: NA • Sponsor: University of Michigan Rogel Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Brain zaps + arm training: new hope for spinal injury patients?
Symptom relief CompletedThe Long-term goal of this project is to develop upper limb rehabilitation interventions that can be utilized for cervical Spinal Cord Injury survivors. This Study will utilize a novel method of non-invasive brain stimulation in conjunction with upper limb training given for 15 …
Phase: PHASE1, PHASE2 • Sponsor: The Cleveland Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New drug combo aims to stop breast cancer return
Disease control OngoingThis research study involves Niraparib as a possible treatment for triple negative breast cancer.
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a viagra drug shield the brain from stroke damage?
Disease control CompletedChronic damage to small blood vessels deep in the brain is seen in half of patients over the age of 60 and almost all patients over the age of 80, and is responsible for up to a third of strokes and almost half of patients with dementia. However, there is limited evidence for how…
Phase: PHASE2 • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Your face could reveal hidden light sensitivity – no words needed
Diagnosis Recruiting nowThe purpose of this project is to provide a new framework for diagnosing and monitoring treatment of light sensitivity and headache by objective measurement of facial features, pupil responses, retinal electrical responses and autonomic nerve responses to light.
Phase: NA • Sponsor: Randy Kardon • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control OngoingThe primary objective of this study is to assess the safety and tolerability and to determine the recommended Phase 2 dose (RP2D) of E7386 in combination with other anticancer drug(s), and to determine the optimal dose of E7386 in combination with lenvatinib in endometrial carcin…
Phase: PHASE1, PHASE2 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New heart shunt device could ease heart failure symptoms
Disease control OngoingThe Exploratory study of the Edwards APTURE transcatheter shunt system (APTURE system) is a multi-center, prospective, exploratory study to evaluate initial clinical safety, device functionality, and effectiveness of the APTURE system.
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental combo aims to fight relapsed blood cancers after transplant
Disease control OngoingIn this research study, our main goal for the ipilimumab portion of the study is to determine the highest dose of ipilimumab that can be given safely in several courses and to determine what side effects are seen in patients with Acute Myeloid Leukemia (AML), Myelodysplastic Synd…
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Scientists hunt for genetic roots of rare childhood blood disorder
Knowledge-focused CompletedCharacterization of the genetic causes, and of the immunopathological clinical and biological manifestations in children with pediatric Evans syndrome included in a prospective national observational cohort of rare diseases.
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
New drug cocktail shows promise for rare muscle disease
Disease control OngoingThis is a Phase 2 prospective open-label treatment study of the safety and efficacy of doxecitine and doxribtimine in study participants with thymidine kinase 2 (TK2) deficiency who participated in the retrospective study MT-1621-101 \[NCT03701568\] or who were receiving nucleos(…
Phase: PHASE2 • Sponsor: UCB BIOSCIENCES, Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New combo tackles Drug-Resistant lung cancer
Disease control OngoingThere are unmet medical needs in patients who resist to EGFR TKIs, especially to osimertinib; APG-1252 shows synergy with osimertinib in both osimertinib treatment naïve and resistant cell lines. This study is to explore the safety and efficacy of the combination of APG-1252 and …
Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Weekly shot may replace daily needles for short stature kids
Disease control OngoingThe study compares 2 medicines used for the treatment of children who are born small and who stayed small: somapacitan given once a week (a new medicine) and Norditropin® given once a day (the medicine doctors can already prescribe). Participants will either get somapacitan or N…
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a common cancer drug prevent relapse after transplant?
Disease control Recruiting nowPrevious studies provide a rationale for administration of AZA after allo SCT for decreasing chimerism. The investigators hypothesize that azacitidine can be well tolerated after SCT and help decrease rate of decreasing donor chimerism and hence decrease relapse without increasin…
Phase: PHASE2 • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Can your own fat cells fix a torn rotator cuff?
Disease control OngoingRotator cuff disease is one of the most prevalent musculoskeletal conditions across the world. Patients with chronic rotator cuff tears often have substantial muscle atrophy and fatty infiltration. Surgical repair of the tear does not reverse the atrophy, and many patients contin…
Phase: PHASE2 • Sponsor: Hospital for Special Surgery, New York • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Walking may slow Parkinson's: new study tests aerobic exercise
Disease control CompletedParkinson's disease (PD) is an incurable brain illness that afflicts more than one million Americans, including many aging Veterans. PD places an unbearable burden on the individual due to progressive impairment of movement and mental function. As a result, patients lose critical…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Psoriasis drug risankizumab tested against rivals in large Real-World study
Disease control CompletedThis study will assess the use of risankizumab in adult patients with moderate to severe chronic plaque psoriasis and compare risankizumab to other commonly used biologics.
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
3-Week radiation blast could spare seniors from 7 weeks of treatment
Disease control CompletedThe purpose of this research study is to investigate a shorter radiation treatment schedule for head and neck cancers in patients 70 years of age and older. Standard radiation treatment for head and neck patients normally requires that the patient travel to the hospital daily fo…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC